Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Based on our recent finding that TACI is mutated in patients with common variable immunodeficiency, of whom more than 30% suffer from autoimmune conditions, we analyzed TACI in humans with SLE.
|
17464555 |
2007 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Disease-modifying heterozygous amino acid substitutions in TACI are found in around ±10% of CVID patients.
|
21815909 |
2011 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Both biallelic and monoallelic TNFRSF13B mutations were identified in patients with common variable immunodeficiency disorders.
|
18981294 |
2009 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A significant association of TNFRSF13B gene mutations was observed in both CVID (p=0.01) and IgAD (p=0.002) Czech patients.
|
22884984 |
2012 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This review focuses on mutations causing four different diseases, which represent distinct pathological mechanisms that can exist within these superfamilies: autoimmune lymphoproliferative syndrome (ALPS; FAS mutations), common variable immunodeficiency (CVID; TACI mutations), tumor necrosis factor receptor associated periodic syndrome (TRAPS; TNFR1 mutations) and hypohidrotic ectodermal dysplasia (HED; EDA1/EDAR mutations).
|
21724465 |
2011 |
Common Variable Immunodeficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Recently, several mutations in genes encoding for molecules (CD19, TACI, ICOS) involved in B cell survival and isotype switch have been identified in patients with CVID.
|
17173844 |
2007 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
B lymphocyte subpopulations, previously defined classification schemes (Freiburg, Paris, EuroClass), TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms were analyzed in 25 common variable immunodeficiency (CVID) patients and 25 healthy controls.
|
22699762 |
2012 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
TNFRSF13B, the gene which encodes transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI), is mutated in nearly 10% of patients with common variable immune deficiency (CVID), an antibody deficiency syndrome characterized by loss of memory B cells and plasma cells.
|
18978466 |
2008 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
TNFRSF13B, which encodes transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), is mutated in 10% of patients with common variable immunodeficiency.
|
20889194 |
2010 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This also confirms the previous suggestion that TNFRSF13B defects alone do not cause CVID and that such an extremely heterogeneous immunodeficiency might be more likely related to additional, still unknown environmental and genetic factors.
|
19494827 |
2009 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The candidate gene approach has led to the detection of associations between common variable immunodeficiency (CVID) and mutations in the genes TACI, ICOS, BAFF-R, CD19, CD20, and CD81.
|
21905497 |
2011 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
One of the 2 most common TACI mutations in CVID, A181E, introduces a negative charge into the transmembrane domain.
|
19605846 |
2009 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding TACI (TNFRSF13B) were previously found to be associated with CVID.
|
22076597 |
2012 |
Common Variable Immunodeficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Viruses and bacteria in bronchoalveolar lavage fluids, protected specimen brush samples, and bronchial biopsies from 14 patients with primary hypogammaglobulinemia (11 patients with common variable immunodeficiency [CVID] and three patients with X-linked agammaglobulinemia [XLA]) were analyzed.
|
10194166 |
1999 |
Common Variable Immunodeficiency
|
0.700 |
Biomarker
|
disease |
BEFREE |
Heterozygous deleterious mutations in the gene encoding the tumor necrosis factor receptor superfamily member 13b (TNFRSF13B), or transmembrane activator and CAML interactor (TACI), have been associated with the development of common variable immunodeficiency.
|
21514638 |
2011 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This work demonstrates that TACI preassembles as an oligomeric complex prior to ligand binding and provides a mechanistic insight into how the heterozygous C104R TACI mutation can potentially lead to CVID.
|
17492055 |
2007 |
Common Variable Immunodeficiency
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Recently, patients with CVID and IGAD have been found to have mutations of the gene TNFRSF13B encoding the TACI (transmembrane activator and calcium-modulator and cyclophilin-ligand interactor), a member of the tumor necrosis factor-receptor superfamily.
|
16899196 |
2006 |
Multiple Myeloma
|
0.450 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to further characterize the role of TACI expression in MM DESIGN AND METHODS: Using gene expression profiling, we investigated whether these patterns are kept in TACI+ or TACI- HMCL.
|
17550853 |
2007 |
Multiple Myeloma
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
FISH analyses of these patients identified one MM carrying a 3.8 Mb amplified region and two MMs with gains specifically involving the TACI locus.
|
17823926 |
2007 |
Multiple Myeloma
|
0.450 |
Biomarker
|
disease |
BEFREE |
This set makes it possible to efficiently classify TACI(hi) and TACI(lo) MMCs in an independent cohort of 40 patients.
|
15827134 |
2005 |
Multiple Myeloma
|
0.450 |
Biomarker
|
disease |
BEFREE |
Taken together, these results define novel APRIL actions via TACI on Tregs and Bregs to promote MM cell survival, providing the rationale for targeting APRIL/TACI system to alleviate the immunosuppressive BM milieu and improve patient outcome in MM.
|
30135465 |
2019 |
Acquired Hypogammaglobulinemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
|
19629655 |
2009 |
Acquired Hypogammaglobulinemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Using a candidate gene approach, we identified homozygous and heterozygous mutations in TNFRSF13B, encoding TACI, in 13 individuals with common variable immunodeficiency.
|
16007087 |
2005 |
Acquired Hypogammaglobulinemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
TACI (transmembrane activator and calcium modulator and cyclophilin ligand interactor) mutations seem to be associated with autoimmunity and common variable immunodeficiency in humans.
|
21850030 |
2012 |
Acquired Hypogammaglobulinemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
TACI is mutant in common variable immunodeficiency and IgA deficiency.
|
16007086 |
2005 |